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Background: DEAD-box helicases in bacteria 
play a key role in cellular RNA metabolism. 
Results: The trimeric protein RraA binds to E. 
coli DEAD-box proteins. 
Conclusion: The mechanism of interaction 
between RraA and SrmB is shown by X-ray 
crystallography. 
Significance: Structural basis of potential 
regulation of a bacterial DEAD-box helicase. 
 
ABSTRACT 
 
Members of the DEAD-box family of RNA 
helicases contribute to virtually every aspect of 
RNA metabolism, in organisms from all 
domains of life. Many of these helicases are 
constituents of multi-component assemblies, and 
their interactions with partner proteins within the 
complexes underpin their activities and 
biological function. In Escherichia coli the 
DEAD-box helicase RhlB is a component of the 
multi-enzyme RNA degradosome assembly, and 
its interaction with the core ribonuclease RNase 
E boosts the ATP-dependent activity of the 
helicase. Earlier studies have identified the 
regulator of ribonuclease activity A (RraA) as a 
potential interaction partner of both RNase E and 
RhlB. We present structural and biochemical 
evidence showing how RraA can bind to, and 
modulate the activity of RhlB and another E. coli 
DEAD-box enzyme, SrmB. Crystallographic 
structures are presented of RraA in complex with 
a portion of the natively unstructured C-terminal 
tail of RhlB at 2.8 Å resolution, and in complex 
with the C-terminal RecA-like domain of SrmB 
at 2.9 Å. The models suggest two distinct 
mechanisms by which RraA might modulate the 
activity of these and potentially other helicases.  
 
 
INTRODUCTION 
 RraA (Regulator of ribonuclease activity 
A) is a ring-shaped homo-trimeric protein with 
the ability in vitro to influence the activity of the 
essential Escherichia coli ribonuclease, RNase E 
(1). As an inhibitor of RNase E, RraA has 
widespread effects on transcript levels in E. coli 
(2), although its physiological role in 
ribonuclease regulation is debated. Surprisingly, 
in vitro RraA does not inhibit the catalytic 
activity of RNase E directly, but appears to act 
indirectly by occluding RNA binding regions in 
the C-terminal domain of the ribonuclease (1). 
These RNA binding domains are adjacent to a 
site that recruits the DEAD-box helicase RhlB, 
in a multi-enzyme assembly known as the RNA 
degradosome. As a component of the RNA 
degradosome, RhlB contributes to mRNA decay 
and RNA processing (3-5). We have previously 
shown that RraA can directly interact with RhlB, 
and it is possible that RraA plays two distinct 
roles in modulating the degradosome, by 
inhibiting both its ribonuclease and helicase 
activities (1). 
 In the Gorna et al study, it was also shown 
that RraA is able to interact in vitro with two 
other DEAD-box proteins from E. coli, namely 
RhlE and SrmB. SrmB is one of the five DEAD-
box proteins in E. coli and is known to 
contribute to ribosome biogenesis along with 
CsdA (DeaD), RhlE and DbpA (6). SrmB targets 
23S rRNA in vivo and forms a ribonucleoprotein 
complex with ribosomal proteins L4 and L24 
(7). SrmB is believed to act as a chaperone by 
preventing 23S rRNA structures from misfolding 
during ribosome assembly, preventing their 
spurious interaction with 5S rRNA (6,8). It also 
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helps to prevent interactions between rRNA 
decay intermediates and nascent 50S ribosome 
subunits (9). 
 Although RhlB is the canonical helicase 
component of the RNA degradosome, other 
DEAD-box helicases may be recruited into the 
assembly depending on growth conditions. For 
instance, under conditions of cold stress, CsdA 
may be recruited to the degradosome (10), and 
SrmB becomes associated during stationary 
growth phase (11). Moreover, the functional 
interplay between helicases and RNase E may be 
important in vivo, as genetic screens show that 
mutations of CsdA suppress the phenotype of 
RNase E defects (12). 
 Here we further investigate the interaction 
between RraA and the DEAD-box helicases of 
E. coli. We present biochemical and structural 
data to characterize the interaction between 
RraA and SrmB, and provide structural data on 
the interaction of RhlB with RraA and compare 
the two complexes. Our data show that RraA can 
modulate SrmB activity and provide structural 
insight into the mechanism. Finally, we elaborate 
on possible functions of the interaction between 
RraA and DEAD-box helicases. 
 
Experimental procedures 
Protein purification 
E. coli BL21(DE3) transformed with 
protein expression vectors were grown at 37ºC in 
2xYT medium (Formedium) supplemented with 
carbenicillin (100 µg/ml) or kanamycin (50 
µg/ml. Expression was induced by addition of 1 
mM isopropyl β-D-thiogalactopyranoside 
(IPTG) at an OD600 nm of 0.5. Cells were 
harvested after 3 hours by centrifugation at 4200 
g, 4 ºC for 30 min and pellets were re-suspended 
in lysis buffer (50 mM Tris/HCl pH 8.0, 100 
mM NaCl, 50 mM KCl, 5 mM MgCl2, Complete 
EDTA-free Protease Inhibitor Cocktail (Roche)). 
In the case of CsdA∆, the lysis buffer was 
supplemented with 300 mM NaCl. Cells were 
lysed with an Emulsiflex-05 cell disruptor 
(Avestin) and the lysate clarified by 
centrifugation (30000 g at 4 ºC for 30 min). 
Molar extinction coefficients (ε280, cm-1 M-1) 
were calculated with ProtParam 
(http://www.expasy.ch/tools/protparam.html). 
Nucleic acid contamination was estimated 
photometrically. All protein samples used were 
free of nucleic acid contamination. 
 
RhlE, SrmB, SrmB1-394 and DbpA 
 RhlE, SrmB, SrmB1-394 (13) and DbpA 
(14) were precipitated from soluble cell lysate 
with ammonium sulphate (60% saturation for 
RhlE, SrmB, DbpA; 40% for SrmB1-394). Pellets 
were harvested by centrifugation, resuspended in 
heparin loading buffer (50 mM Tris/HCl pH 7.5, 
50 mM NaCl), and loaded onto a HiTrap heparin 
HP column (GE Healthcare). Proteins were 
eluted with a linear gradient to 100% heparin 
load buffer supplemented with 2M NaCl, and the 
purified proteins were pooled and stored at  
-80º C until required. 
 
CsdA∆ 
Vector pROEX-HT encoding a truncated 
CsdA (CsdA∆) with N-terminal His-tag was a 
generous gift from Dr M. Dreyfus and Dr T. 
Bizebard (CNRS, University Paris, Institut de 
Biologie Physico-chimique, France). Clarified 
lysate from induced cells was loaded onto a 
HisTrap FF column (GE-Healthcare), washed 
with buffer containing 50 mM Tris/HCl pH 7.5, 
150 mM NaCl, 50 mM (NH4)2SO4 and a gradient 
was developed to 100% wash buffer 
supplemented with 250 mM imidazole. 
Collected fractions were supplemented with 2 
mM DTT and 2 mM EDTA, dialyzed against 
storage buffer (20 mM Tris/HCl pH 7.5, 500 
mM NaCl, 10 mM DTT) and stored at -80º C. 
 
RhlB398-421 peptide 
A peptide corresponding to residues 
398-421 of RhlB with an additional tyrosine to 
enable photometric estimation of peptide 
concentration was synthesized by EZBiolab Inc 
(YRLTRPRTGNGPRRTGAPRNRRRSG). The 
peptide was reconstituted in 20 mM sodium 
phosphate buffer pH 7.5. 
 
RraA 
 RraA was expressed and purified as 
described previously (1). 
 
Analytical Ultracentrifugation (AUC) 
Sedimentation velocity experiments 
were performed using an XL-I analytical 
ultracentrifuge (Beckman), An60-Ti (Beckman) 
rotor and absorbance optics. Absorbance was 
monitored at 280 nm. The centrifugation was 
performed at 45000 rpm and 20 ºC with scans 
every 2 minutes. All proteins used in this set of 
experiments were exchanged into the following 
buffer: 150 mM NaCl, 50 mM HEPES pH 7.5, 
10% glycerol (w/v). For experiments involving 
CsdA∆ the buffer contained 300 mM NaCl and 2 
mM TCEP (tris(2-carboxyethyl) phosphine) as 
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reducing agent. The mixtures were at 1:1 ratio of 
helicase:RraA trimer. The sample volume was 
400 µl and concentration was adjusted so the 
OD280 nm was between 0.8 and 1.0, 
corresponding to final protein concentrations of 
approximately 10 µM. Recorded data were 
analyzed using SEDFIT software (15). Buffer 
density, viscosity and partial specific volumes 
were calculated using SEDNTERP (16). The 
profiles and fits are presented in supplementary 
material Figures S2-6. 
 
Small Angle X-ray Scattering (SAXS) 
SrmB and its complex with RraA 
proteins were dialyzed at 4 ºC against buffer 
containing 150 mM NaCl, 20 mM HEPES pH 
7.0, 5% v/v glycerol, 2 mM DTT. SAXS data 
were collected at the Deutsches Elektronen-
Synchrotron (DESY, Hamburg, Germany) at 
beamline X33. Scattering profiles were recorded 
at 15 °C for various concentrations of protein 
samples (5 to 55 µM). Data were analyzed using 
the ATSAS package (17). Solvent scattering 
measurements were averaged and subtracted 
from the sample data. The radius of particle 
gyration (Rg) was estimated from the scattering 
profile at small angle (|s| < 1.3/Rg) using the 
Guinier approximation (18). GNOM software 
(19) was used to estimate maximum particle 
diameter (Dmax) and to calculate the distance 
distribution function P(r). Ab initio modeling 
was performed using DAMMIF (20), which 
reconstructs the shape of a particle using dummy 
beads in a sphere of diameter equal to Dmax. 
DAMMIF reconstructions were performed using 
the University of Cambridge CamGrid 
computing cluster (21). Multiple independent 
reconstructed shapes were aligned, 
superimposed, averaged and filtered using 
DAMAVER and SUBCOMB (22). The quality 
of averaged shapes was evaluated by the normal 
spatial discrepancy (NSD) value (23), which 
measures dissimilarity between the individual 
reconstructed shapes. NSD values greater than 
0.7 are an indication of an unstable solution (22), 
and the value for the SrmB/RraA complex was 
0.62 suggesting a good degree of similarity 
between individual models. 
Protein crystallization 
SrmB and RraA were mixed at a 1:3 
molar ratio and concentrated to 8.7 mg/ml. 
Crystals were prepared using the hanging drop 
method at 16 ºC by mixing 1 µl of the sample 
with 1 µl of mother liquor (100 mM magnesium 
acetate, 100 mM MOPS pH 7.2 and 12% w/v 
PEG (polyethylene glycol) 8000). Crystals 
appeared after 4 weeks but dissolved after a 
further week. Soon after the crystals appeared 
they were transferred briefly to reservoir solution 
supplemented with 25% (v/v) glycerol and flash 
frozen in liquid nitrogen. 
 For co-crystallization of RraA with 
RhlB398-421 peptide, components were mixed at 
1:20 concentration ratio of RraA:RhlB398-421. The 
mixture precipitated but could be solubilized at 
higher ionic strength, resulting in final 
concentrations 74.8 µM RraA, 1.48 mM RhlB398-
421, 423 mM NaCl, 99 mM (NH4)2SO4. Co-
crystals were obtained using the hanging drop 
method, by mixing 1 µl of protein sample with 1 
µl of mother liquor (100 mM sodium citrate pH 
5.4, 32% MPD (methyl-pentanediol) and 200 
mM ammonium acetate) at 16 ºC. Crystals were 
directly flash frozen in liquid nitrogen. 
 X-ray diffraction data were collected at 
the Diamond Light Source synchrotron radiation 
facility (Harwell, UK) at 100 K. SrmB/RraA 
crystal diffracted to 2.9 Å, and the RraA/RhlB 
peptide crystal diffracted to 2.8 Å. The CCP4 
suite (24) was used for data processing, 
molecular replacement, model building, 
refinement and other calculations. Data were 
processed using Mosflm (25) Pointless and Scala 
(26). Molecular replacements were performed 
using Phaser (27) with search models: RraA 
(PDB code: 1Q5X) and Vasa (both domains 
were used separately with all residues mutated to 
alanine, PDB code: 2DB3). Manual model 
building was performed using Coot (28). 
Automated model building and sequence 
docking was performed using ARP/wARP (29) 
and Buccaneer (30). Automated refinement was 
performed using Refmac5 (31). The structures 
were analyzed by Areaimol, PISA (32) and 
Superpose (33). The crystallographic and 
refinement summary are presented in Table 1. 
 
ATP turnover assays 
 ATPase activity of DEAD-box proteins 
was monitored using the EnzCheck Phosphate 
Assay Kit (Invitrogen) following the 
manufacturers instructions. All proteins were 
exchanged into the following assay buffer: 100 
mM NaCl, 50 mM Tris/HCl pH 7.5, with the 
exception of CsdA∆ which requires high salt for 
stability and was exchanged into the assay buffer 
supplemented with 500 mM NaCl. The final 
concentrations of DEAD-box helicases were 1 
µM except for DbpA, which was used at a final 
concentration of 2 µM. RraA was added in three 
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fold or six fold molar excess over helicase. 
 Two types of RNA substrates were used 
in these reactions. The first was a mixture of 16S 
and 23S rRNA from E. coli (Roche), for which 2 
µg was added to each reaction. The second RNA 
was a self-complementary 24-mer (5'-
GAAUGUACAUCAGAGUGCGCACUC-3') 
which anneals to a 12 bp region and has a 12 bp 
5' ssRNA overhang (5) and was used at a final 
concentration of 1 µM. Reactions were started 
with the addition of a mixture of ATP and 
MgCl2 (1:1, mol:mol) to a final concentration of 
2 mM. 
 The final reaction volume was 200 µl 
containing 5 mM DTT and the salt concentration 
was kept constant at 50 mM NaCl. Absorption at 
360 nm was measured in MicroWell 96-Well 
plates (VWR) in a plate reader (Molecular 
Devices Spectramax Plus) for 900 seconds and 
the temperature were kept constant at 30 ºC. All 
reactions were performed in triplicate or greater. 
Absorbance values were converted to the 
corresponding phosphate concentration using a 
standard curve. The activity was expressed as 
moles of inorganic phosphate released per 
minute per mol of protein. The reactions of RhlE 
and CsdA∆ with 16S and 23S rRNA were 
characterized by a rapid release of phosphate 
followed by a plateau phase, therefore a time 
point of 150 seconds instead of 900 seconds was 
used. Contaminating inorganic phosphate 
present in the ATP and MgCl2 mixture was 
quantified and subtracted from the results. 
 
Electrophoretic mobility shift assays (EMSA) 
Reactions were in a final volume 20 µl 
and included 4 µl of loading buffer: 50% v/v 
glycerol, 0.05% w/v bromophenol blue, 50 mM 
Tris, 384 mM glycine, pH 8.3. Reactions were 
separated on 5% native polyacrylamide gels 
(acrylamide:bisacrylamide 37.5:1, 200 mM 
Tris/HCl pH 8.5, 10% v/v glycerol) in 1 x 
Tris/Glycine running buffer containing 1 mM 
DTT at 120 V for 160-180 min at 4 ºC. Proteins 
were exchanged into the following buffers using 
Micro Bio-Spin 6 columns (Bio-Rad): RraA and 
CsdAΔ (50 mM HEPES pH 7.5, 300 mM NaCl, 
10% glycerol (w/v), 2 mM TCEP (tris(2-
carboxyethyl)phosphine)); DbpA, RhlE and 
SrmB (50 mM HEPES pH 7.5, 10% glycerol (w/ 
v), 150 mM NaCl). Final helicase and RraA 
concentrations were 10 µM and 30 µM 
respectively unless indicated otherwise. For 
further analysis, selected bands were extracted, 
incubated with 4 x NuPAGE LDS Sample 
Buffer (Invitrogen) supplemented with 5% (v/v) 
β-mercaptoethanol for 30 min at 95 ºC then 
buffer with eluted protein was loaded onto 10% 
Bis-Tris NuPAGE SDS-PAGE gel (Invitrogen). 
Subsequent electrophoresis was performed at 
180 V for 90-120 min using SDS-MOPS buffer.  
 
Site-Directed Mutagenesis 
  Site-Directed Mutagenesis was 
performed using Phusion Site-Directed 
Mutagenesis Kit according to manufactures 
instructions (Thermo Scientific). 
 
RESULTS 
 
RraA interaction with SrmB and RhlB 
A direct protein-protein interaction has 
previously been identified between RraA and 
RhlB. The interaction strength was estimated by 
surface plasmon resonance to have a dissociation 
constant of 80 µM, however, EMSA assays 
estimate the dissociation constant to be 10 µM 
(1). To investigate this interaction further we 
analyzed the RraA-RhlB protein complex using 
analytical ultracentrifugation (AUC). RhlB and 
RraA were found to sediment as single species in 
a molecular mass range close to 50 kDa, 
corresponding to the expected mass of trimeric 
RraA (52 kDa) and the monomeric RhlB (47 
kDa). When RraA and RhlB were mixed at a 3:1 
molar ratio (of protomers), at 10 µM total protein 
concentration, a faster sedimenting species with 
apparent mass near 100 kDa was observed 
(Figure 1A). Similarly, when a mixture of RraA 
and SrmB was analysed by AUC at a similar 
concentration, again a species corresponding to a 
complex of approximately 100 kDa was 
observed (the SrmB monomer has a molecular 
mass of 50 kDa). These data suggest RraA is 
capable of forming a direct interaction with 
either RhlB or SrmB in vitro, and the observed 
100 kDa mass for both complexes corresponds 
to an assembly of one RraA trimer and one 
helicase monomer.  
The interaction of RraA with SrmB was 
further corroborated by electromobility shift 
assays (EMSA) using non-denaturing 
polyacrylamide gels (Figure 1E). Bands 
corresponding to an RraA-helicase complex 
were excised from the gel, and subsequent 
analysis by SDS-PAGE confirmed the presence 
of both helicase and RraA proteins in the single 
gel band.  
When simply comparing the AUC 
profiles of the complexes of RraA with SrmB or 
Interactions of DEAD-box helicases with RraA 
 5 
RhlB the data suggests that the affinity of RraA 
for SrmB is greater than for RhlB.  The majority 
of SrmB and RraA co-sediment in the 100 kDa 
peak, with little free RraA or SrmB, suggesting 
the dissociation constant for this interaction is 
well below 10 µM. However, the RraA-RhlB 
mixture shows a significant amount of protein 
remains in the 50 kDa peak, suggesting a weaker 
interaction (compare Figures 1A and 1B). 
 Our previous investigations of the 
complex between RhlB and RraA showed that 
this interaction is mediated almost exclusively 
through the RhlB C–terminal extension (CTE) 
(1). In the present study we have confirmed by 
isothermal titration calorimetry a direct 
interaction between RraA and RhlB CTE (data 
not shown). Given that the AUC data indicates 
SrmB forms a similar complex with RraA as 
RhlB we performed AUC with a truncated SrmB 
lacking the C-terminal extension (SrmB1-394) to 
establish if this interaction is also mediated 
through the CTE of the helicase. Surprisingly 
deletion of the CTE of SrmB does not abolish 
the interaction with RraA, in contrast to the 
results with RhlB, indicating that the SrmB core 
is also involved in this interaction (Figure 1C). 
Formation of a complex with RraA is somewhat 
less efficient with the truncated SrmB protein 
(compare Figures 1B and 1C), suggesting that 
the CTE contributes to this interaction, but is not 
essential for complex formation. 
 
RraA modulates RNA-dependent ATPase 
activity of SrmB 
 We have previously shown that the 
interaction between RraA and RhlB reduces the 
ATPase activity of the helicase (1). The capacity 
of RraA to bind to SrmB raises the question of 
whether this interaction has a similar inhibitory 
effect. To address this question, we compared 
rates of ATP turnover by SrmB in the presence 
and absence of RraA. The proteins were mixed 
at a 1:1 ratio (helicase monomer:RraA trimer) in 
line with the stoichiometry predicted from our 
AUC experiments, and in the presence of an 
RNA substrate. 23S rRNA has been shown to be 
a substrate for SrmB (6,8), and using a mixture 
of E. coli 23S and 16S rRNA, mild inhibition of 
ATPase activity was observed in the presence of 
RraA. The effect was much more pronounced 
with a corresponding concentration (in 
nucleotides) of a self-complementary 24-mer 
RNA which forms a short (12 bp) RNA duplex 
with 12 bp 5' overhangs (Figure 1D). The RNA 
24-mer is an artificial construct and is likely to 
be a non-specific substrate for E. coli DEAD-
box helicases (34). The results indicate that the 
formation of a complex with RraA can modulate 
the ATPase activity of SrmB and that the 
magnitude of the effect depends on the nature of 
RNA substrate. A stronger inhibitory effect of 
RraA in the presence of non-specific substrates 
might help to boost the apparent fidelity of the 
helicase. 
 
Structural basis of RraA interactions with 
DEAD-box proteins 
Complex between RraA and SrmB 
To obtain insights into how the 
interaction of RraA with SrmB might influence 
the activity of the helicase, we obtained solution 
and crystal structures of this complex. We first 
performed Small Angle X-ray Scattering 
(SAXS) to obtain the low-resolution envelope 
for the complex formed by mixing SrmB and 
RraA at a 1:3 molar ratio. This envelope can 
accommodate a single RraA trimer with a single 
SrmB helicase bound to the outer ring of RraA, 
consistent with the 1:3 molar ratio indicated by 
analytical ultra-centrifugation analyses (Figure 
2A). 
We co-crystallized the two proteins and 
solved the crystal structure at 2.9 Å resolution by 
molecular replacement using the structures of 
RraA [(35) – PDB 1Q5X] and a poly-alanine 
model prepared from a single RecA-domain of 
the Drosophila Vasa helicase [(36) – PDB 
2DB3]. The crystallographic asymmetric unit 
contains a single torus-shaped trimer of RraA 
bound to one SrmB RecA-like α/β sandwich 
domain (Figure 2B). For each of the three RraA 
protomers, residues 2-159 could be modelled, 
and the entire trimer superimposes with a RMSD 
of 0.41 Å with the original structure of this 
protein (35). The crystallographic data and 
refinement statistics are summarized in Table 1. 
Following close inspection of the 
electron density maps it was clear that the RecA-
like domain resolved in the crystal structure 
corresponds to the CTD of SrmB (residues 219-
388). The CTD has a typical DEAD-box protein 
fold and engages the outside rim of the RraA 
trimer, such that only one RraA protomer is 
engaged with the SrmB CTD. There are no 
significant structural changes in the RraA 
protomer that contacts the SrmB CTD compared 
to the two protomers not bound to SrmB. The 
presence of only the C-terminal RecA-like 
domain of SrmB in the crystal structure was 
unexpected. Insufficient protein crystals were 
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obtained to evaluate their protein content by 
SDS-PAGE, but gel analysis of the entire 
crystallization droplet suggested that SrmB was 
intact in solution. However, it is possible that the 
CTD of SrmB may have been liberated by 
proteolysis during crystal genesis. The last 56 
residues of SrmB corresponding to the CTE, 
which are predicted to be natively unstructured, 
were also not resolved in the final model, and 
this may indicate that this region is indeed 
disordered.  Other DEAD-box proteins have 
flexible N- and C-terminal extensions that are 
often not modelled in their crystal structures, 
with few exceptions (37). 
Inspection of the interface between 
SrmB and RraA reveals electrostatic 
complementarity formed by a positively charged 
patch on SrmB and a negatively charged cluster 
on RraA. The interface involves mainly salt 
bridging interactions of side chains and 
hydrogen bonds between main chain atoms. 
Most of the RraA residues involved in the 
interaction with SrmB are conserved (Figure S1) 
and two of these residues (D50, E53) were 
predicted earlier to be involved in RraA 
interactions with other proteins (38). In contrast 
the SrmB residues involved in the interaction lie 
outside of regions of high sequence conservation 
in DEAD-box proteins. 
The role of the identified interface in 
stabilising the complex was tested by site 
directed mutagenesis (Figure 3). Recombinant 
RraA proteins were generated with a single 
amino acid mutation at residue D128, and a 
double mutation of D50 and E53. Similarly, 
SrmB was expressed and purified with a single 
mutation at residue R310. The chosen amino 
acids were substituted for both oppositely 
charged residues, and alanine. In all cases the 
substitutions inhibited complex formation as 
assessed by electrophoretic mobility shift assay. 
 
Complex between RraA and RhlB398-421 
Unlike the interaction between RraA and 
SrmB, the complex formed between RraA and 
RhlB appears to be mediated entirely by the C–
terminal extension (CTE) of RhlB. Despite 
extensive efforts we were unable to co–
crystallize RraA with full-length RhlB, however 
it was possible to obtain co-crystals of RraA 
with a peptide corresponding to the RhlB CTE 
(RhlB398-421). The structure of RhlB398-421/RraA 
was solved at 2.8 Å resolution, and reveals 
twelve protomers of RraA in the asymmetric unit 
of the crystal, organized as stacked trimers that 
generate two hexamers. The hexameric form of 
RraA may be a favoured oligomerisation state at 
higher protein concentrations, as hexameric 
assemblies also occur in the crystal structure of 
isolated RraA (35). 
The electron density maps were clear 
and well resolved for all the RraA protomers. 
Poorer quality electron density was identified on 
the surface of a single RraA protomer that is able 
to accommodate a single RhlB398-421 peptide 
(Figure 4A). The identified density is likely to 
originate from RhlB398-421 as there are no 
elongated molecules (e.g. polyethylene glycol) 
in the crystallization condition that may account 
for the continuous density. Due to the poor 
quality of the density it was not possible to 
model amino acid side-chains for the peptide, 
but 15 of 23 main chain residues could be traced 
with confidence (two chains of 6 and 9 residues, 
Figure 4A). The two segments of the traced main 
chain likely belong to one molecule; however, 
the discontinuity in the electron density did not 
allow the fragments to be joined with 
confidence. The density is located close to 
electronegative patches on the RraA surface, 
which is compatible with the complementary 
electropositive nature of RhlB398-421 (predicted pI 
12.5). As the peptide side chains could not be 
modeled unequivocally, it is not possible to 
derive detailed information about the RhlB398-
421/RraA interface. Nonetheless, the structure 
indicates an approximate site of RhlB fragment 
binding on the surface of RraA. Surprisingly, the 
contact site overlaps with the interface identified 
for the SrmB/RraA assembly (Figure 4B) and 
the modeled RhlB residues lay in proximity of 
RraA residues D50 and D128. This suggests that 
RraA harbours one surface region that is the 
binding site for both RhlB and SrmB. 
 
Interactions of RraA with other DEAD-box 
enzymes 
The findings presented here indicate that 
RhlB and SrmB use different recognition modes 
to interact with RraA. We investigated whether 
RraA might interact with the remaining three 
DEAD-box helicases encoded by the E. coli 
genome, namely DbpA, CsdA and RhlE. 
Notably, AUC and EMSA analysis revealed that 
all of the DEAD-box proteins studied bind to 
RraA in vitro, albeit to various extents (Figure 
5A, B, F, G and H). In the case of DbpA AUC 
revealed a single species in a molecular mass 
range close to 50 kDa, corresponding to the 
expected mass of monomeric DbpA (49 kDa). 
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As we have seen for RhlB and SrmB, when 
DbpA was mixed with RraA a new species was 
observed with a mass of 100 kDa, which 
suggests a similar stoichiometry to the RraA 
complex with SrmB and RhlB (Figure 5A). 
Interaction of DbpA with RraA was confirmed 
using EMSA (Figure 5 F). 
Earlier studies have reported that full 
length CsdA has a tendency to aggregate in 
vitro, but a truncated version consisting of 
residues 1 to 443 (CsdA∆) was found to have 
greater solubility whilst retaining ATPase 
activity (39). For the purpose of completeness 
we included CsdAΔ in our AUC analyses, but 
appreciate that the removal of the CTE of CsdA 
may have a detrimental effect on the formation 
of a complex with RraA. For the AUC analyses 
of CsdA∆ undertaken here, we found that it was 
necessary to elevate the NaCl concentration in 
the buffer to 300 mM to prevent protein 
precipitation. Under these conditions the AUC 
profile suggests that CsdA∆ forms a dimer, with 
a single species observed with estimated mass of 
100 kDa. The same high salt conditions also 
increased the apparent molecular mass of RraA 
to ~100 kDa, which may correspond to 
hexameric RraA (Figure 5B). The sample with 
both RraA and CsdA∆ showed a major peak of 
100 kDa accompanied by a shoulder of greater 
mass (~150 kDa), which may correspond to a 
complex of both proteins (Figure 5B). However, 
with these analyses we cannot confidently 
determine the stoichiometry of the RraA:CsdA∆ 
complex. Interaction of CsdA∆ with RraA was 
confirmed using EMSA (Figure 5 G). 
The final E. coli DEAD-box helicase we 
investigated was RhlE. However, when RhlE 
was mixed with RraA the solution rapidly 
precipitated, and consequently it was not 
possible to confirm the formation of an 
RhlE/RraA complex by AUC. We were however 
able to confirm the interaction of RhlE with 
RraA using EMSA (Figure 5 H).  
Next we investigated if the identified 
interactions with RraA can also influence the 
activities of DbpA, RhlE and CsdA∆ using 23S 
rRNA or a synthetic 24-mer RNA substrate. The 
results revealed moderate effects of RraA on 
ATPase activities compared with SrmB (Figure 
5C-E). We also did not observe a clear 
dependence on RNA substrate, in contrast to our 
observations with SrmB.  
It is interesting to note that the ATPase 
activity of DbpA, CsdAΔ and RhlE were all 
enhanced in the presence of E. coli 23S and 16S 
rRNA, and all but DbpA were activated by the 
24-mer RNA substrate. The results are consistent 
with  earlier findings that DbpA specifically 
requires 23S rRNA to be active (40). The results 
also agree with reports that RhlE exhibits the 
greatest ATPase activity of the E. coli DEAD-
box helicases (Figure 5C) (39).  
 
DISCUSSION 
Here we have provided structural details 
of the interaction between RraA and the DEAD-
box helicases RhlB and SrmB. The SrmB/RraA 
crystal structure is in good correspondence with 
the shape reconstructed from SAXS data and 
with the stoichiometry suggested by AUC. SrmB 
interacts on the outside rim of the RraA trimer 
torus and not with the negatively charged 
grooves present at the protomer interfaces as 
previously suggested (1). Our structural data 
suggest that a common surface on RraA is used 
for the interactions with RhlB and SrmB. The 
biological role of this interaction, and 
additionally the interactions we have observed 
with other E. coli DEAD-box proteins in vitro 
will require further in vivo investigations. Our 
enzymatic assays suggest that RraA is capable of 
modulating the ATPase activity of these 
conserved enzymes, and this is likely to have 
functional consequences if the interactions also 
occur in vivo. 
Our in vitro enzymatic assays were 
performed in the micromolar concentration 
range, and the dissociation constants for the 
helicase:RraA interactions are likely to be low-
micromolar. It is estimated that there are roughly 
1350 molecules of RhlB, 1000 of DbpA, and 500 
to 1000 of RraA in an E. coli cell [(41,42); 
George Georgiou, personal communication], and 
these values would correspond to micromolar 
concentrations. Accordingly, binding of RraA 
and the helicases is expected to occur in vivo if 
the molecules have mutual access.  
Based on our structural data, we propose 
a mechanism to explain how RraA impedes 
SrmB activity. Superposition of the SrmB/RraA 
complex structure onto the crystal structure of 
the human DEAD-box helicase Dbp5 in complex 
with RNA and an ATP analogue (PDB code: 
3FHT) reveals that bound RraA would prevent 
SrmB from adopting the closed conformation 
seen for the Dbp5 structure (Figure 6A). It is 
well known that a closed helicase conformation 
is required for ATP turnover and RNA 
unwinding (43). Closer inspection of the 
superimposed helicase structures reveals that 
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bound RraA partially occludes the RNA binding 
surface of SrmB. If RNA were to be bound to 
SrmB in a similar manner to the interaction seen 
for Dbp5, it would clash sterically with a loop on 
the surface of RraA consisting of residues 53-59 
(Figure 6B). Based on these structural overlays, 
we propose that RraA can influence SrmB 
activity by sterically inhibiting substrate binding 
and by preventing the enzyme from adopting the 
closed conformation required for ATP 
hydrolysis. 
Similar mechanisms of inhibiting 
DEAD-box proteins have been described 
previously. For instance, in the crystal structure 
of the eukaryotic DEAD-box helicase Dbp5 in 
complex with NUP214 nucleoporin (PDB code: 
3FHC) the N-terminal RecA-like domain of 
Dbp5 contacts the N-terminal region of 
NUP214, and this interaction prevents the 
helicase from adopting a closed conformation 
and restricts RNA binding (44). It was possible 
to superpose the CTD of SrmB in complex with 
RraA onto the NTD of Dbp5 bound to NUP214. 
This overlay reveals that both protein partners 
(RraA and NUP214) are bound on equivalent 
surfaces of the helicase RecA-like domains 
(Figure 6C). Furthermore, the interaction 
between Dbp5 and NUP214 is also primarily 
mediated by surface charge complementarity. 
However, unlike RraA, NUP214 binds to 
conserved sequence motifs of the DEAD-box 
enzyme (44,45). Another inhibitory partner of 
DEAD-box proteins is the tumor suppressor 
Programmed Cell Death Protein 4 (PDCD4), 
which forms a complex with eIF4A helicase 
(46). However, the mode of binding in this 
complex is slightly different as PDCD4 engages 
both domains of eIF4A simultaneously (Figure 
6D). 
Interestingly the mechanism observed 
for SrmB seems not to be applicable in the case 
of RhlB, as this DEAD-box enzyme contacts 
RraA through an unstructured C-terminal 
extension (CTE). As the RhlB C-terminal 
extension plays a role in non-specific binding of 
RNA substrates (5), by binding to the CTE, 
RraA would compete with non-specific RNA 
binding. It was experimentally demonstrated for 
RhlB that the positively charged CTE is required 
for ATP turnover in the presence of RNA 
(13,47). The importance of the C-terminal 
extensions of DEAD-box proteins in binding to 
RNA substrates has recently been highlighted in 
both Mss116p of Saccharomyces cerevisiae and 
CYT-19 of Neurospora crassa, where the CTEs 
have been shown by SAXS to bind non-
specifically to large RNA substrates (48). In the 
proposed model for inhibition of RhlB, the RraA 
would not contact the RNA binding sites located 
in the helicase core as it does in the case of 
SrmB, but instead sequester the CTE.  
Recently, SrmB was shown to 
specifically target 23S rRNA, and the helicase 
has been proposed to prevent formation of 
misfolded RNA structures during ribosome 
assembly (6-8). We have seen a much stronger 
inhibitory effect of RraA in the presence of a 
non-specific 24-mer RNA, rather than a specific 
RNA substrate, i.e., 23S rRNA. Thus we 
hypothesize that a possible function of the RraA 
interaction with SrmB is to impede the helicase’s 
action on non-specific substrates. Unsupervised 
enzyme action could lead to futile expenditure of 
ATP, misfolded RNA species and consequently 
inefficient or erroneous ribosome assembly. 
The interaction between RraA and SrmB 
is a potential link between regulation of RNA 
levels in the E. coli cell and ribosome 
biogenesis. The RraA protein concentration 
varies during the E. coli growth cycle, increasing 
more than five fold during late logarithmic 
growth phase (49), and this variation may have 
impact on helicase activity. Logarithmic phase is 
characterized by intensive ribosome biogenesis, 
while in stationary phase de novo ribosome 
synthesis is minimal (50,51). One role of RraA 
could therefore be to inhibit SrmB activity 
during transition from logarithmic to stationary 
growth phase and to exercise control over its 
specificity.  
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Figure legends 
Figure 1. Stoichiometric and functional analysis of RraA complex with DEAD-box helicases 
SrmB and RhlB. 
The mass distribution for helicases, RraA and the mixtures are shown in blue, red and black 
respectively. A, B, C: Analytical ultracentrifugation of  RhlB, SrmB, and SrmB1-394 in the 
presence and absence of RraA. D) Effects of RraA on the ATPase activity of SrmB. White 
and dark grey bars represent reactions with 24-mer RNA substrate in the absence and 
presence of RraA, respectively. Reactions with a mixture of 23S and 16S rRNA in the 
absence and presence of RraA are represented by light grey bars and bars filled with diagonal 
stripes. When present, RraA was added in three fold molar excess to helicase. Activity is 
expressed as mol Pi/min/mol protein. Each bar represents averaged values from at least three 
independent experiments and represent two standard deviations. E) Interactions of SrmB and 
RraA evaluated by native polyacrylamide gel elecrophoresis. Free RraA migrates with the 
buffer front, but due to its positive charge, free SrmB does not enter the gel. The band 
corresponding to a complex of the two proteins (marked with asterisk) was extracted and 
analysed by SDS-PAGE, confirming the presence of both RraA and SrmB. 
 
Figure 2. The solution and crystal structures of the SrmB-RraA complex. 
A) An averaged ab initio SAXS model of SrmB-RraA complex, shown from two viewpoints 
related by a 90º rotation. B) The content of the crystal asymmetric unit (two viewpoints 
related by a 90º rotation – as in figure 2A). The RraA trimer is colored salmon with the 
protomer contacting SrmB shown in red, SrmB CTD is shown in blue. The N- and C-termini 
of SrmB are marked by “N” and “C” respectively. 
 
Figure 3. Analysis of molecular interactions between RraA and SrmB. A and B  Interactions 
of  WT and mutated proteins evaluated by electrophoretic mobility shift assays. Final SrmB 
and RraA concentrations were 2.5 µM and 7.5 µM respectively. Panels C and D highlight 
residues mutated for these analyses. SrmB is light blue and RraA is colored salmon. For 
clarity, side chains of residues that do not interact directly with mutated residues are not 
shown. 
 
Figure 4. Crystal structure of RraA in complex with the C-terminal extension of RhlB 
(RhlB398-421). 
A) The RhlB fragment is shown in sticks representation (green). The black mesh represents a 
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2Fo-Fc electron density map. RraA is colored red. B) Superposition of SrmB CTD (blue) 
bound to RraA on the RhlB fragment. The RraA trimer is shown in red, and RhlB398-421 is 
shown in green. 
 
Figure 5. RraA and its interactions with DbpA, CsdA and RhlE helicases. 
Panels A and B show AUC analysis. The mass distribution for helicases, RraA and the 
mixtures are shown in blue, red and black, respectively. A): DbpA and RraA. B) AUC 
analysis of CsdA∆, RraA and their complex (in 300 mM NaCl). Both proteins form particles 
of mass ~100 kDa, which corresponds to a CsdA∆ dimer and RraA hexamer. When both 
proteins are present a predominant peak is recorded with a shoulder of ~150 kDa, which 
likely correspond to an assembly between the CsdA∆ with RraA. Panels C, D, E: Effects of 
RraA on ATPase activity of the helicases. Each bar represents averaged values from at least 
three independent experiments and represent two standard deviations. White and dark grey 
bars represent reactions with 24-mer RNA substrate. Reactions with 23S, 16S rRNA are 
represented by light grey bars and bars filled with diagonal stripes. Bars that are dark grey or 
filled with diagonal stripes represent reactions with RraA. RraA was added in three fold 
molar excess (one RraA trimer per helicase molecule). In the case of CsdA∆ with 23S, 16S 
rRNA and DbpA twice the amount of RraA was used (two RraA trimers per helicase 
molecule). Activity is expressed as mol Pi/min/mol protein, and the scale differs for 
individual helicases. Panels F, G and H: Interactions of RraA, with the DEAD-box helicases 
analysed by native PAGE. Free RhlE does not enter the gel. Bands marked with an asterisk 
were extracted and analysed by SDS-PAGE to confirm the presence of both RraA and 
DEAD-box proteins. 
 
Figure 6. Comparison of the RraA/SrmB structure and other DEAD-box protein complexes. 
A) RraA bound to SrmB would prevent RecA-like domain closure due to steric clash 
(highlighted by dashed frame). SrmB is colored blue, the RraA protomer interacting with 
RraA is shown in red and the other RraA protomers are shown in grey. The Dbp5 structure in 
closed conformation (PDB code: 3FHT), superimposed onto SrmB CTD is shown in cyan 
with RNA colored yellow and shown in stick representation. The RMSD for the fit is 1.34 Å. 
B) RraA binding may impede RNA binding by SrmB. The RraA loop consisting of residues 
53-59 would occlude the predicted RNA binding surface of SrmB (highlighted by dashed 
frame). C) Comparison of the RraA/SrmB and Dbp5/NUP214 complexes. The reference 
frame for the overlay is the SrmB CTD (blue) and the Dbp5 NTD (cyan). RraA is red and  
NUP214 is yellow  (PDB code: 3FHC). D) Comparison of the RraA/SrmB and 
eIF4A/PDCD4 complexes. Superposition of SrmB CTD (blue) on eIF4A NTD (cyan). 
PDCD4 is shown in yellow(PDB code: 2ZU6). The overlays are shown from two viewpoints 
related by a 90º rotation. 
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Table 1 
 
 RraA + SrmB RraA + RhlB(398-421) 
Crystallisation 
condition 
100 mM MOPS pH 7.2 
12% PEG 8000 
100 mM Magnesium acetate 
100 mM Sodium citrate pH 5.4 
MPD 32% (v/v) 
200 mM Ammonium acetate 
Space group P3221 C121 
Cryo-protectant 25% glycerol (v/v) — 
Wavelength (Å) 0.9763 0.9795 
Resolution (Å) 63.56-2.90 (3.06-2.90) 63.53-2.80 (2.95-2.80) 
 Unit cell dimensions 
a,b, c (Å) 73.39, 73.39, 222.89 259.63, 69.07, 123.30 
α, β, γ (º) 90.00, 90.00, 120.00 90.00, 109.17, 90.00 
Completeness (%) 99.6 (99.5) 98.0 (99.3) 
Multiplicity 4.0 (4.1) 2.9 (2.9) 
I/sigma 10.2 (2.8) 15.5 (3.7) 
Rmerge (%) 12.3 (50.8) 4.9 (25.9) 
 Refinement 
Reflections 15208 47500 
R factor 0.2012 0.2303 
Rfree 0.2509 0.2900 
Bond lengths rmsd (Å) 0.0228 0.0168 
B factor protein (Å2) 42 46 
Atoms 4993 14445 
Residues 673 1970 
Table 1. Crystallographic data and refinement summary. 
Values for highest resolution shell are shown in parentheses. Five percent of the reflections 
were set aside for calculation of the Rfree. Crystallographic and refinement statistics were 
calculated by Scala (26) and Refmac5 (31) respectively. 
  
Interactions of DEAD-box helicases with RraA 
 14 
Figure 1 
 
  
Interactions of DEAD-box helicases with RraA 
 15 
Figure 2 
 
  
Interactions of DEAD-box helicases with RraA 
 16 
Figure 3 
 
  
Interactions of DEAD-box helicases with RraA 
 17 
Figure 4 
 
  
Interactions of DEAD-box helicases with RraA 
 18 
Figure 5 
 
  
Interactions of DEAD-box helicases with RraA 
 19 
Figure 6 
 
 
